Shirley D'Sa/LinkedIn
Nov 13, 2026, 13:27
Shirley D’Sa: Connecting European and Mayo Clinic Experts in MGCS Research and Care
Shirley D’Sa, Professor of Haematology at UCL Cancer Institute, Advisory Council Member at Harvard Business Review, shared a post on LinkedIn:
“It was great to connect with haematologists, neurologists, nephrologists, rheumatologists, dermatologists from across Europe and Mayo Clinic to talk about monoclonal gammopathies of clinical significance MGCS including CAD – cold agglutinin disease.
Nothing beats siting in the same room with colleagues from other disciplines.
Thank you to our hosts Karl Landsteiner University.”
Other posts featuring Shirley D’Sa on Hemostatis Today.
-
Nov 13, 2026, 13:20Josie Sirna: Representing the Thalassemia Community at Canada’s Rare Disease Conference in Halifax
-
Nov 13, 2026, 13:14Annalisa Ruggeri: 18 Years in Haematology – Celebrating a Journey at San Raffaele
-
Nov 13, 2026, 13:08Did You Know That 20–30% of Female Hemophilia Carriers Experience Bleeding Symptoms? – Haemophilia Foundation Australia
-
Nov 13, 2026, 12:12Issac Cheong: POCUS Detection of IVC Filter Thrombosis With Right Atrial Extension
-
Nov 13, 2026, 11:57Dianne E. van der Wal: Red Blood Cell Engineering and the Role of Cytokine Glycosylation
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health